Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety and Efficacy of SWK002 in Patients With D2T-Rheumatoid Arthritis

NCT06503237 is registered in ClinicalTrials.gov with The First Affiliated Hospital of University of Science and Technology of China as lead sponsor.

NCT NCT06503237
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06503237 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety and Efficacy of SWK002 in Patients With D2T-Rheumatoid Arthritis
Lead sponsor
The First Affiliated Hospital of University of Science and Technology of China
Phase
Not applicable
Overall status
Recruiting
Start date
November 9, 2023
Completion date
March 31, 2026
Enrollment
18 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

rheumatoid arthritis